Squarepoint Ops LLC Sells 42,555 Shares of Inspire Medical Systems, Inc. $INSP

Key Points

• Squarepoint Ops LLC cut its Inspire Medical Systems stake by 63.7% in the second quarter, selling 42,555 shares and retaining 24,259 shares valued at approximately $1.08 million.
• Institutional ownership remains high at 94.91%, with several major investors—including Corient Private Wealth, UBS Asset Management and Van ECK Associates—adding to their positions.
• Analyst sentiment is mixed: the stock has a consensus “Hold” rating and a $66.50 price target, while recent quarterly results exceeded expectations with $0.14 EPS and $200.58 million in revenue.

Squarepoint Ops LLC lowered its position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 63.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,259 shares of the company's stock after selling 42,555 shares during the quarter. Squarepoint Ops LLC owned 0.08% of Inspire Medical Systems worth $1,082,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. Allworth Financial LP increased its position in Inspire Medical Systems by 275.7% in the 2nd quarter. Allworth Financial LP now owns 1,980 shares of the company's stock valued at $88,000 after acquiring an additional 1,453 shares during the period. Nykredit A S acquired a new position in shares of Inspire Medical Systems during the second quarter worth $78,000. Corient Private Wealth LP lifted its holdings in shares of Inspire Medical Systems by 993.8% during the second quarter. Corient Private Wealth LP now owns 57,535 shares of the company's stock worth $2,567,000 after purchasing an additional 52,275 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Inspire Medical Systems by 21.7% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 546,020 shares of the company's stock worth $24,358,000 after purchasing an additional 97,233 shares during the period. Finally, Van ECK Associates Corp grew its stake in shares of Inspire Medical Systems by 24.2% in the second quarter. Van ECK Associates Corp now owns 5,267 shares of the company's stock worth $235,000 after purchasing an additional 1,025 shares during the last quarter. Institutional investors own 94.91% of the company's stock.

Analyst Upgrades and Downgrades

INSP has been the subject of several analyst reports. Truist Financial reaffirmed a "hold" rating and set a $62.00 target price (up from $54.00) on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Zacks Research upgraded Inspire Medical Systems from a "hold" rating to a "strong-buy" rating in a research report on Monday, August 17th. UBS Group assumed coverage on Inspire Medical Systems in a research note on Tuesday, July 28th. They issued a "sell" rating and a $39.00 price target for the company. Bank of America downgraded Inspire Medical Systems from a "neutral" rating to an "underperform" rating and set a $39.00 price objective for the company. in a research report on Friday, May 22nd. Finally, Mizuho lifted their price objective on Inspire Medical Systems from $55.00 to $65.00 and gave the stock an "outperform" rating in a research note on Tuesday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $66.50.

Inspire Medical Systems Price Performance

NYSE INSP opened at $72.89 on Friday. The stock has a market capitalization of $2.11 billion, a P/E ratio of 15.78, a P/E/G ratio of 5.53 and a beta of 0.70. The business has a 50 day simple moving average of $58.99 and a 200 day simple moving average of $52.93. Inspire Medical Systems, Inc. has a one year low of $38.91 and a one year high of $147.03.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.38. The firm had revenue of $200.58 million for the quarter, compared to analysts' expectations of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The company's revenue for the quarter was down 7.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 EPS. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Equities analysts expect that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current year.

Insider Buying and Selling

In other Inspire Medical Systems news, insider Jason Kelly sold 963 shares of the firm's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the sale, the insider directly owned 18,985 shares in the company, valued at approximately $1,130,556.75. This trade represents a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.20% of the company's stock.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company's primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.